21062 ⎘
Medicinal preparations containing antigens or antibodies; Vertebrate antigens Nervous system antigens; Prions
Detection of Structural Forms of Proteins
#2Methods of Formulating a Vaccine
#3VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND NGF ANTIGENS
#4Compositions of Phosphorylated Tau Peptides and Uses Thereof
#5Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease
#6Method of Safe Administration of Phosphorylated TAU Peptide Vaccine
#7ARTIFICIAL PROMISCUOUS T HELPER CELL EPITOPES THAT FACILITATE TARGETED ANTIBODY PRODUCTION WITH LIMITED T CELL INFLAMMATORY RESPONSE
#8A CONJUGATE COMPRISING AT LEAST A ß-GLUCAN
#9MULTIEPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#10PEPTIDE CONJUGATE VACCINE COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#11Anti-Alpha-Synuclein Therapeutic Vaccines
#12Liposomes Containing Phosphorylated Tau Peptides for Inducing Sustained Immune Responses
#13METHOD OF TREATING PRECLINICIAL ALZHEIMER'S DISEASE
#14ACTIVE IMMUNIZATION FOR REDUCING OSTEOARTHRITIC, NEUROPATHIC, AND CANCER PAIN
#15ANTIBODIES TO AMYLOID BETA
#16METHOD OF SAFE ADMINISTRATION OF TAU PHOSPHOPEPTIDE CONJUGATE
#17METHODS AND MATERIALS TO TREAT NEURODEGENERATIVE DISEASE
#18Anti-Abeta Therapeutic Vaccines
#19Multi-epitope vaccine for the treatment of Alzheimer's disease
#20IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE
#21Universal mRNA Vaccine to Treat Dementia-Causing Neurodegenerative Disorders
#22Vaccine Therapy
#23PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE
#24Phosphorylated Polypeptide Antigen Vaccine, Preparation Method Therefor and Application Thereof
#25IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE
#26TAU PEPTIDE IMMUNOGEN CONSTRUCTS
#27Peptide
#28PARTICLES ENCAPSULATING FUSION PROTEINS CONTAINING LINKED EPITOPES
#29IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOF
#30Method of Safe Administration of Phosphorylated TAU Peptide Vaccine
#31ß-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER’S DISEASE
#32MULTIEPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#33Tau Immunotherapy
#34Multi-epitope vaccine for the treatment of Alzheimer's disease
#35Multi-epitope vaccine for the treatment of Alzheimer's disease
#36Multi-epitope vaccine for the treatment of Alzheimer's disease
#37Immunogenic Compounds
#38Heterologous Administration of Tau Vaccines
#39VACCINE FOR TREATING MULTIPLE SCLEROSIS
#40MONOCLONAL ANTIBODIES AGAINST PATHOLOGICAL TAU, AND METHODS USING SAME
#41VACCINE THERAPY FOR RAN PROTEIN DISEASES
#42MIMOTOPES OF ALPHA-SYNUCLEIN AND VACCINES THEREOF FOR THE TREATMENT OF SYNUCLEINOPATHY
#43Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease
#44Cyclic Peptides
#45IMMUNOTHERAPEUTIC MODULATION OF AMYLOIDOGENIC DISEASE USING NON-FIBRILLOGENIC, NON-AMYLOIDOGENIC POLYMERIZED PROTEINS AND PEPTIDES
#46EXTRACELLULAR VESICLES FOR TREATING NEUROLOGICAL DISORDERS
#47COMPOSITIONS AND METHODS FOR THE TREATMENT OF TAUOPATHY
#48COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF PRION DISEASE
#49MODIFIED VIRUS-LIKE PARTICLES OF CMV
#50VACCINE FORMULATIONS
#51DNA VACCINE AGAINST AMYLOID-BETA AND TAU
#52TAU PEPTIDE ANTIGENS AND ANTIBODIES BINDING THERETO FOR THE TREATMENT OF TAUOPATHIES
#53Humanized anti-A β monoclonal antibody and application thereof
#54ANTI-ABETA VACCINE THERAPY
#55Innocuous, structured scaffolds for structure-based amyloid disease vaccines and antigens
#56TREATMENT OF ALZHEIMER'S DISEASE (AD) WITH AN ALUMINUM SALT
#57Immunotherapeutic compositions for the treatment of Alzheimer's disease
#58GLIAL FIBRILLARY ACIDIC PROTEIN TARGETING IMMUNO- AND APTAMER-BASED-THERAPY FOR NEUROINJURY, NEURODEGENERATION, NEURO-DISEASE, AND NEURO-REPAIR
#59ARTIFICIAL PROMISCUOUS T HELPER CELL EPITOPES THAT FACILITATE TARGETED ANTIBODY PRODUCTION WITH LIMITED T CELL INFLAMMATORY RESPONSE
#60Peptide
#61PROTEIN-BASED THERAPY AND DIAGNOSIS OF TAU-MEDIATED PATHOLOGY IN ALZHEIMER'S DISEASE
#62CD4 T cells provide antibody access to immunoprivileged tissue
#63Compositions of Phosphorylated Tau Peptides and Uses Thereof
#64METHOD OF PROVIDING PATIENT SPECIFIC IMMUNE RESPONSE IN AMYLOIDOSES AND PROTEIN AGGREGATION DISORDERS
#65MUTATED TAU PROTEIN FRAGMENT AND USE THEREOF
#66AMYLOSPHEROID (ASPD)-LIKE STRUCTURE AND PHARMACEUTICAL COMPOSITION
#67APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS
#68N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
#69PEPTIDE IMMUNOGENS FROM THE C-TERMINAL END OF ALPHA-SYNUCLEIN PROTEIN AND FORMULATIONS THEREOF FOR TREATMENT OF SYNUCLEINOPATHIES
#70Tau peptide immunogen constructs
#71Methods for diagnosing and treating Alzheimer's disease
#72Anti-abeta therapeutic vaccines
#73MATERIALS AND METHODS FOR THE TREATMENT OF LEWY BODY DISORDERS
#74Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide
#75Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide
#76Immunological targeting of pathological tau proteins
#77Nanobodies suitable for neuron regeneration therapy
#78PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE
#79METHODS AND SYSTEMS FOR IDENTIFICATION AND TREATMENT OF PATHOLOGICAL NEURODEGENERATION AND AGE-RELATED COGNITIVE DECLINE
#80Compositions of phosphorylated tau peptides and uses thereof
#81Heterologous administration of tau vaccines
#82Treatment of Alzheimer's Disease (AD) with an aluminum salt
#83DEAD ANTIGEN STIMULATED IMMATURE HETEROGENOUS DENDRITIC CELLS AS THERAPEUTICS FOR DISEASES
#84APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS
#85Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy
#86Method of safe administration of phosphorylated tau peptide vaccine
#87ANTI-TAU CONSTRUCTS
#88Anti-transthyretin human antibody
#89Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomers
#90Modified virus-like particles of CMV
#91Tau immunotherapy
#92Use as immune enhancer or pharmaceutical composition for treatment of dementia, comprising phytosphingosine-1-phosphate or derivative thereof
#93Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment
#94Immunotherapeutic compositions for the treatment of Alzheimer's disease
#95METHODS OF IMMUNE MODULATION AGAINST FOREIGN AND/OR AUTO ANTIGENS
#96PARTICLES ENCAPSULATING FUSION PROTEINS CONTAINING LINKED EPITOPES
#97Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides
#98Mutated tau protein fragment and use thereof
#99Anti-abeta therapeutic vaccines
#100PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE
#101PEPTIDE
#102CHIMERIC RECEPTORS AND METHODS OF USE THEREOF
#103Compositions of phosphorylated tau peptides and uses thereof
#104Method for vaccination against a self-antigen in a human patient
#105Individualized Immunomodulation Therapy for Neurodegenerative Disorders, CNS Injury and Age-Related Dementia
#106Isolated polypeptide and compositions comprising same
#107Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#108N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
#109EPITOPES IN AMYLOID BETA AND CONFORMATIONALLY-SELECTIVE ANTIBODIES THERETO
#110Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#111Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins
#112Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease
#113DNA molecules encoding antibodies to tau and methods of making thereof
#114METHOD AND VACCINE COMPRISING COPOLYMER 1 FOR TREATMENT OF PSYCHIATRIC DISORDERS
#115CHIMERIC RECEPTORS AND METHODS OF USE THEREOF
#116DNA vaccine against amyloid-β and tau
#117Methods of treating neurodegenerative disorders
#118Method of providing patient specific immune response in amyloidoses and protein aggregation disorders
#119IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE
#120COMPOSITIONS AND METHODS RELATED TO NEUROLOGICAL DISORDERS
#121PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE
#122CD4 T cells provide antibody access to immunoprivileged tissue
#123Modified virus-like particles of CMV
#124Substances and methods for the use in prevention and/or treatment in Huntington's disease
#125Nanobodies suitable for neuron regeneration therapy
#126Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease
#127COMPOSITIONS AND METHODS RELATED TO NEUROLOGICAL DISORDERS
#128Adjuvant composition containing citrulline
#129Methods for diagnosing and treating Alzheimer's disease
#130HCBI, MSBI, MSSI AND CMI SEQUENCES AS AN EARLY MARKER FOR THE FUTURE DEVELOPMENT OF CANCER AND DISEASES OF THE CNS AND AS A TARGET FOR THE TREATMENT AND PREVENTION OF THESE DISEASES
#131USE OF LEUKOCYTES AND NOVEL BIOMARKERS IN THE DIAGNOSIS, CONFIRMATION, AND TREATMENT OF A NEUROLOGICAL DISORDER
#132Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
#133Methods and kits for detecting brain injury
#134USING B-CELL-TARGETING ANTIGEN IGG FUSION AS TOLEROGENIC PROTEIN THERAPY FOR TREATING ADVERSE IMMUNE RESPONSES
#135Immunotherapeutic compositions for the treatment of alzheimer's disease
#136Method and system for reducing the likelihood of a spirochetes infection in a human being
#137Treatment of alzheimer'S disease (AD) with an aluminum salt
#138Vaccines for protection from and treatment of alzheimer's disease
#139Antibodies specific to pyroglutamated Aβ
#140METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#141METHOD OF PROVIDING PATIENT SPECIFIC IMMUNE RESPONSE IN AMYLOIDOSES AND PROTEIN AGGREGATION DISORDERS
#142Anti-transthyretin humanized antibody
#143Tau peptides, anti-tau antibodies, and methods of use thereof
#144Anti-transthyretin human antibody
#145Method for treating amyloid disease
#146RECOMBINANT T-CELL RECEPTOR LIGAND FOR THE TREATMENT OF COGNITIVE AND NEUROPSYCHIATRIC IMPAIRMENT INDUCED BY SUBSTANCE ADDICTION
#147Methods of using myelin basis protein peptide compositions
#148COMBINATIONS OF AGGREGATING PROTEINS AND MOLECULAR CHAPERONE PROTEINS FOR THE TREATMENT OF PROTEINOPATHIES OR CONFORMATIONAL DISEASES
#149Diagnostic Test and Treatment/Prevention of Alzheimer's Disease
#150Methods and compositions for inhibiting diseases of the central nervous system
#151Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
#152Vaccine formulations comprising quillaja desacylsaponins and beta amyloid peptides or tau protein to induce a Th2 immune response
#153Inhibition of the synthesis of beta-app or the activity of the A-β peptide in the choroid plexus
#154APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS
#155Disaccharide synthetic lipid compounds and uses thereof
#156Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
#157Tau immunotherapy
#158METHOD FOR TREATING A beta-AMYLOIDOSIS
#159IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOF
#160Amyloid beta1-6 Antigen Arrays
#161Local engineering of the lymph node environment to promote immune tolerance
#162PEPTIDE
#163Standardized ex vivo platforms for the antigen-specific expansion of CD4+ T cell populations
#164Peptide-based compounds and uses thereof to treat beta-amyloid accumulation
#165Antibodies that bind amyloid oligomers
#166Prion epitopes and methods of use thereof
#167METHOD FOR TREATING A SYNUCLEIOPATHY
#168Vaccine for treatment of tautopathy
#169INDIVIDUALIZED IMMUNOMODULATION THERAPY FOR NEURODEGENERATIVE DISORDERS, CNS INJURY AND AGE-RELATED DEMENTIA
#170Compositions and methods related to diseases associated with deposits of amyloid, tau, and alpha-synuclein
#171Immunization with rabies virus vector expressing foreign protein antigen
#172Antibodies obtainable using supramolecular constructs
#173DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
#174Method for treating amyloid disease
#175Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins
#176Disaccharide synthetic lipid compounds and uses thereof
#177COMPOSITION
#178COMPOSITIONS
#179Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease
#180Mucosal immunization to prevent prion infection
#181Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
#182Prion disease-specific epitopes and methods of use thereof
#183Composition Comprising the Amyloid Beta 1-6 Peptide Coupled to a Virus-Like Particle and an Adjuvant
#184Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
#185Amyloid Beta 1-6 Antigen Arrays
#186Methylated peptides derived from tau protein and their antibodies for diagnosis and therapy of alzheimer's disease
#187Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
#188Vaccines for protection from and treatment of alzheimer's disease
#189IMMUNOTHERAPY FOR TREATMENT OF AMYLOID-RELATED DISORDERS USING ENCAPSULATED BETA-AMYLOID PEPTIDES
#190Methods of using myelin basic protein peptide compositions
#191Vaccine and method for treatment of neurodegenerative diseases
#192Albumin-amyloid peptide conjugates and uses thereof
#193Adjuvant composition containing citrulline
#194Method for enhancing immune response with peptide
#195Diagnosis and treatment of Alzheimer's disease
#196Methods and compositions for inhibiting diseases of the central nervous system
#197Vaccine engineering
#198T-cell therapy to neurodegenerative diseases
#199Disaccharide synthetic lipid compounds and uses thereof
#200Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
#201Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
#202COMPOUNDS FOR TREATING BETA-AMYLOIDOSES
#203Method for preparing liposome-based constructs
#204Methods for inhibiting C5a with C5a peptides coupled or fused to a carrier protein
#205Prevention and treatment of alzheimer's disease by amyloid beta peptide and sphin-gosine-1-phosphate
#206Vaccine for treatment of tautopathy
#207Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins
#208Regulatory proteins and inhibitors
#209DNA vaccine for Alzheimer's disease
#210AMYLOID BETA PEPTIDES, ASSEMBLIES THEREOF, AND RELATED METHODS
#211Prevention And Treatment Of Amyloidogenic Disease
#212Method for treating amyloid disease
#213Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides
#214Composition Comprising the Amyloid Beta 1-6 Peptide Coupled to a Virus-Like Particle and an Adjuvant
#215Prevention and Treatment of Amyloidogenic Disease
#216PREVENTION, TREATMENT AND DIAGNOSIS OF DISEASES ASSOCIATED WITH BETA-AMYLOID FORMATION AND/OR AGGREGATION
#217Nucleic acid molecules encoding anti-amyloid beta antibodies
#218A-β immunogenic peptide carrier conjugates and methods of producing same
#219PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE
#220Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
#221Polynucleotides encoding an anti-beta-amyloid monoclonal antibody
#222Means for treating synucleinopathies
#223Antibodies that bind amyloid oligomers
#224Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
#225Albumin-amyloid peptide conjugates and uses thereof
#226Molecular Antigen Array
#227Method for enhancing immune response with peptide
#228VECTOR FOR TREATING ALZHEIMER'S DISEASE
#229Vaccine composition for prophylaxis and/or therapy of Alzheimer's disease
#230Methods and compositions comprising supramolecular constructs
#231Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
#232DNA VACCINE FOR ALZHEIMER'S DISEASE
#233Prevention and Treatment of Amyloidogenic Disease
#234Molecular Antigen Array
#235Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
#236PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#237A-β immunogenic peptide carrier conjugates and methods of producing same
#238CHIMERIC PEPTIDES AS IMMUNOGENS, ANTIBODIES THERETO, AND METHODS FOR IMMUNIZATION USING CHIMERIC PEPTIDES OR ANTIBODIES
#239Modified amyloid β peptide
#240Methods and compositions for eliciting an amyloid-selective immune response
#241Composition for producing anti-amyloid beta peptide antibodies with D-peptides
#242Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
#243Immunotherapeutic compositions for the treatment of alzheimer'S disease
#244Vaccine and method for treatment of neurodegenerative diseases
#245COMBINATION THERAPY FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE, AND KIT THEREFOR
#246PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#247PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#248PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC DISEASE
#249IMMUNOTHERAPY COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF AMYLOIDOSIS
#250COMPOSITIONS AND METHODS FOR DIAGNOSIS, STRATIFICATION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#251Compounds for treating beta-amyloidoses
#252Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
#253Composition comprising VLP and amyloid beta peptide
#254Angiotensin peptide-carrier conjugates and uses thereof
#255Vaccine for alzheimer's disease
#256Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance
#257Immunizing composition and method for inducing an immune response against the β-secretase cleavage site of amyloid precursor protein
#258PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#259PEPTIDE CONJUGATE COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE
#260Glycopeptides and methods of making and using them
#261AGENTS AND METHODS FOR TREATMENT OF ANXIETY DISORDERS
#262VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#263Peptide vaccine using mimic molecules of amyloid β peptide
#264METHODS AND SUBSTANCES FOR THE TREATMENT OF ALZHEIMER'S
#265Immunological targeting of pathological Tau proteins
#266High Molecular Weight Amyloid Beta As a Carrier for the Oral Delivery of Vaccine Antigens
#267Method of providing patient specific immune response in amyloidoses and protein aggregation disorders
#268Method for enhancing immune response with peptide
#269Myelin basic protein peptide composition
#270Method for therapeutic use
#271Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins
#272Prevention and treatment of synucleinopathic and amyloidogenic disease
#273AMYLOID BETA(1-42) OLIGOMERS, DERIVATIVES THEREOF AND ANTIBODIES THERETO, METHODS OF PREPARATION THEREOF AND USE THEREOF
#274ACTIVE OR PASSIVE IMMUNIZATION AGAINST PROAPOPTOTIC NEUROTROPHINS FOR THE TREATMENT AND/OR PREVENTION OF NEURODEGENERATIVE DISEASES
#275Aß(X - 38 .. 43) oligomers, and processes, compositions, and uses thereof
#276PREVENTIVE AND THERAPEUTIC VACCINE FOR ALZHEIMER'S DISEASE
#277Anti-Aβ antibodies and their use
#278COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE DISEASE
#279Method for Preparing a Covalently Cross Linked Oligomer of Amyloid Beta Peptides
#280Immunotherapy for Treatment of Amyloid-Related Disorders Using Encapsulated Beta-Amyloid Peptides
#281Method of treatment of age-related macular degeneration
#282Methods and compositions for the treatment and diagnosis of cancer
#283Prevention and treatment of synucleinopathic and amyloidogenic disease
#284Amyloid-beta polypeptide vaccine
#285Methods and compositions for inhibiting diseases of the central nervous system
#286Immunogenic memapsin 2 β-secretase peptides and methods of use
#287FILAMENTOUS BACTERIOPHAGE DISPLAYING PROTEIN AS A BINDER OF ANTIBODIES AND IMMUNOCOMPLEXES FOR DELIVERY TO THE BRAIN
#288NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#289Neurotoxic oligomers
#290PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#291PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#292PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#293POLYNUCLEOTIDE THERAPY
#294Prion epitopes and methods of use thereof
#295POLYNUCLEOTIDE THERAPY
#296Amyloid beta receptor and uses thereof
#297PREVENTIVE AND THERAPEUTIC VACCINE FOR STORKE AND NEUROLOGICAL DISORDERS
#298Amyloid beta1-6 antigen arrays
#299Methods for Promoting Neurite Outgrowth and Survival of Dopaminergic Neurons
#300Treatment and delay of outset of synucleinopathic and amyloidogenic disease